Keyword Connections

glioblastoma

Journals

31

1 Scientific reports

2 The Analyst

3 International journal of molecular sciences

4 The Journal of biological chemistry

5 Theranostics

6 Chemical communications (Cambridge, England)

7 Journal of visualized experiments : JoVE

8 world neurosurgery

9 Cells

10 journal of neuro-oncology

11 clinical & translational oncology : official publication of the federation of spanish oncology societies and of the national cancer institute of mexico

12 Cancers

13 van sağlık bilimleri dergisi

14 Biochemical and biophysical research communications

15 journal of neurosurgery

16 Neuro-Oncology

17 zeitschrift fur naturforschung c, journal of biosciences

18 The Journal of neuroscience : the official journal of the Society for Neuroscience

19 Journal of cancer research and clinical oncology

20 advances in experimental medicine and biology

21 Practical radiation oncology

22 Aging

23 international journal of radiation oncology, biology, physics

24 molecular therapy nucleic acids

25 drug delivery and translational research

26 Acta neurochirurgica

27 Pneumologie

28 current cancer drug targets

29 neurosurgery

30 electromagnetic biology and medicine

31 cardiovascular pathology : the official journal of the society for cardiovascular pathology

Research Groups

0

No Research Group Connected

Bibliographies

166

1 GLİOBLASTOMA’da 5-FU ve CELASTROL’ün SİTOTOKSİK ETKİSİ

2 A Tunable Nanoplatform of Nanogold Functionalised with Angiogenin Peptides for Anti-Angiogenic Therapy of Brain Tumours.

3 Single-cell RNA-seq reveals RAD51AP1 as a potent mediator of EGFRvIII in human glioblastomas.

4 Non-invasive Imaging of Cancer Using Surface-Enhanced Spatially Offset Raman Spectroscopy (SESORS).

5 Improved Dynamic Light Scattering using an adaptive and statistically driven time resolved treatment of correlation data.

6 Magnetic Resonance Imaging as a Biomarker in Rodent Peripheral Nerve Injury Models Reveals an Age-Related Impairment of Nerve Regeneration.

7 A sound-sensitive source of alpha oscillations in human non-primary auditory cortex.

8 The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy.

9 Frequency and Evolution of New Postoperative Enhancement on 3 Tesla Intraoperative and Early Postoperative Magnetic Resonance Imaging.

10 A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).

11 Safety and efficacy of VB-111, an anti-cancer gene-therapy, in patients with recurrent glioblastoma: results of a phase I/II study.

12 Impact of extremely low-frequency electromagnetic field (100 Hz, 100 G) exposure on human glioblastoma U87 cells during Temozolomide administration.

13 RNF213 suppresses carcinogenesis in glioblastoma by affecting MAPK/JNK signaling pathway.

14 MicroRNA-129 Inhibits Glioma Cell Growth by Targeting CDK4, CDK6, and MDM2.

15 Objective assessment of intraoperative tumor fluorescence reveals biological heterogeneity within glioblastomas: a biometric study.

16 Effects of Arginine and Its Deprivation on Human Glioblastoma Physiology and Signaling.

17 Signaling Determinants of Glioma Cell Invasion.

18 Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.

19 Hypofractionated radiation therapy versus standard fractionated radiation therapy with concurrent temozolomide in elderly patients with newly diagnosed glioblastoma.

20 A Modern Radiotherapy Series of Survival in Hispanic Patients with Glioblastoma.

21 Timing of Adjuvant Radiotherapy in Glioblastoma Patients: A Single-Institution Experience With More Than 400 Patients.

22 Identification of tissue factor in experimental aortic valve sclerosis.

23 Role of the CCAAT/enhancer-binding protein NFATc2 transcription factor cascade in the induction of secretory phospholipase A2.

24 Comparison of the efficacy and acute toxicity of weekly versus daily chemoradiotherapy for non-small-cell lung cancer: a meta-analysis.

25 Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy.

26 Applications of magnetoliposomes with encapsulated doxorubicin for integrated chemotherapy and hyperthermia of rat C6 glioma.

27 Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route.

28 4-nerolidylcatechol induces autophagy in human glioblastoma cells

29 immunotherapeutic advancements for glioblastoma

30 bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern

31 pembrolizumab activity in recurrent high-grade gliomas with partial or complete loss of mismatch repair protein expression: a monocentric, observational and prospective pilot study

32 shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma

33 treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case report

34 molecular evolution of a glioblastoma controlled with tumor treating fields and concomitant temozolomide

35 expression of cathepsins b, d, and g in isocitrate dehydrogenase-wildtype glioblastoma

36 avastin in clinical chemotherapy of malignant tumors

37 potential applications of image-guided radiotherapy for brain metastases and glioblastoma to improve patient quality of life

38 the future of glioblastoma therapy: synergism of standard of care and immunotherapy

39 diffusion weighted/tensor imaging, functional mri and perfusion weighted imaging in glioblastoma—foundations and future

40 the impact of the tumor microenvironment on the properties of glioma stem-like cells

41 waiting time to radiotherapy as a prognostic factor for glioblastoma patients in a scenario of medical disparities

42 advances in radiotherapy for glioblastoma

43 emerging insights into barriers to effective brain tumor therapeutics

44 exosome proteome of u-87mg glioblastoma cells

45 in vitro effect of 8-prenylnaringenin and naringenin on fibroblasts and glioblastoma cells-cellular accumulation and cytotoxicity

46 immunosuppressive mechanisms of malignant gliomas: parallels at non-cns sites

47 the divergence in bacterial components associated with bactrocera dorsalis across developmental stages

48 treatment resistance mechanisms of malignant glioma tumor stem cells

49 diagnostic and prognostic significance of methionine uptake and methionine positron emission tomography imaging in gliomas

50 cdk4/6 inhibitor pd0332991 in glioblastoma treatment: does it have a future?

51 aberrant signaling pathways in glioma

52 glioblastoma multiforme: a look inside its heterogeneous nature

53 wilms' tumor protein 1 and enzymatic oxidation of 5-methylcytosine in brain tumors: potential perspectives

54 extracellular vesicles as modulators of tumor microenvironment and disease progression in glioma

55 hsp90 inhibitor nms-e973 exerts the anticancer effect against glioblastoma via induction of puma-mediated apoptosis

56 delineation of radiation therapy target volumes for patients with postoperative glioblastoma: a review

57 pineal region glioblastoma, a case report and literature review

58 Anoikis resistance conferred by tenascin-C-derived peptide TNIIIA2 and its disruption by integrin inactivation.

59 Multicolour chemical imaging of plant tissues with hyperspectral stimulated Raman scattering microscopy.

60 Creation of active water-splitting photocatalysts by controlling cocatalysts using atomically precise metal nanoclusters.

61 Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions.

62 Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition

63 Glioma Surgical Aspirate: A Viable Source of Tumor Tissue for Experimental Research

64 CHRDL1 Regulates Stemness in Glioma Stem-like Cells.

65 [Test Your Knowledge].

66 Gene Expression of /CD114 Is Associated with Poorer Patient Survival in Glioma.

67 A proof-of-principle for decontamination of transplantation kidney through UV-C exposition of the perfusate solution.

68 Glioblastoma Cell Derived Exosomes as a Potent Vaccine Platform Targeting Primary Brain Cancers and Brain Metastases.

69 Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation.

70 Virtual Clinical Trial Reveals Significant Clinical Potential of Targeting Tumor-Associated Macrophages and Microglia to Treat Glioblastoma.

71 Synthesis and biological evaluation of 2.4 nm thiolate-protected gold nanoparticles conjugated to Cetuximab for targeting glioblastoma cancer cells via the EGFR.

72 Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma.

73 Integration of Radiomic and Multi-omic Analyses Predicts Survival of Newly Diagnosed IDH1 Wild-Type Glioblastoma.

74 Flavonoids from the Brazilian plant Croton betulaster inhibit the growth of human glioblastoma cells and induce apoptosis

75 Flavonoids from the Brazilian plant Croton betulaster inhibit the growth of human glioblastoma cells and induce apoptosis

76 GLİOBLASTOMA’da 5-FU ve CELASTROL’ün SİTOTOKSİK ETKİSİ

77 Dehydroabietylamine Ureas and Thioureas as Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Enhance the Antitumor Effect of Temozolomide on Glioblastoma Cells.

78 Combined SOM-portrayal of gene expression and DNA methylation landscapes disentangles modes of epigenetic regulation in glioblastoma

79 Exploring new applications of tulip tree (Liriodendron tulipifera L.): leaf essential oil as apoptotic agent for human glioblastoma.

80 Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma.

81 In Vitro Effect of 8-Prenylnaringenin and Naringenin on Fibroblasts and Glioblastoma Cells-Cellular Accumulation and Cytotoxicity

82 The role of microRNA-148a and downstream DLGAP1 on the molecular regulation and tumor progression on human glioblastoma.

83 miRNA-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiforme.

84 Exploiting Microglial Functions for the Treatment of Glioblastoma.

85 Exploiting microglial functions for the treatment of glioblastoma

86 Long noncoding RNA forms a growth promoting complex with HNRNPL in human glioblastoma through stabilization of ACTN4 and activation of NF-κB signaling.

87 COMBINING ELLAGIC ACID WITH TEMOZOLOMIDE MEDIATES THE CADHERIN SWITCH AND ANGIOGENESIS IN A GLIOBLASTOMA MODEL.

88 Mass Effect Deformation Heterogeneity (MEDH) on Gadolinium-contrast T1-weighted MRI is associated with decreased survival in patients with right cerebral hemisphere Glioblastoma: A feasibility study

89 The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells

90 Romiplostim for temozolomide-induced thrombocytopenia in glioblastoma: The PLATUM trial.

91 Comparison and analysis of lncRNA-mediated ceRNA regulation in different molecular subtypes of glioblastoma.

92 A tumor-targeting nanomedicine carrying the p53 gene crosses the blood–brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma

93 Integrated Approach Reveals Role of Mitochondrial Germ-Line Mutation F18L in Respiratory Chain, Oxidative Alterations, Drug Sensitivity, and Patient Prognosis in Glioblastoma

94 PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database

95 Sequencing and curation strategies for identifying candidate glioblastoma treatments.

96 Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study.

97 Quercetin: A promising phytochemical for the treatment of glioblastoma multiforme.

98 Cerebellar giant cell glioblastoma multiforme in an adult

99 Primary spinal glioblastoma treated with adjuvant radiation and temozolomide: Report of two cases.

100 Corrigendum to "The modulating effect of lipid bilayer/p-coumaric acid interactions on electrical properties of model lipid membranes and human glioblastoma cells" [Bioorg. Chem. 92 (2019) 103242].

101 A Multiparametric Model for Mapping Cellularity in Glioblastoma Using Radiographically Localized Biopsies.